Global /Japan /Healthcare /Drug Manufacturers - General /4574

Taiko Pharmaceutical Co.,Ltd.

4574

• TSE: 4574 • Delayed

292JPY -0.3%

1.82 USD

As of 8 June 2026, Taiko Pharmaceutical Co.,Ltd. has a market cap of $91.53M USD, ranking #26169 globally and #2319 in Japan. It ranks #2349 in the Healthcare sector, and #848 in the Drug Manufacturers - General industry.

Global Rank

26169

Country Rank

2319

Sector Rank

2349

Industry Rank

848

Key Stats

Market Cap

$91.53MUSD

14.67B JPY

Enterprise Value

$70.14MUSD

11.23B JPY

Revenue (TTM)

$39.9MUSD

6.4B JPY

EBITDA (TTM)

$4.52MUSD

724.0M JPY

Net Income (TTM)

$5.76MUSD

923.0M JPY

EBITDA Margin

11%

Profit Margin

14%

PE Ratio

15.9

Forward PE

22.6

PS Ratio

2.3

PB Ratio

1.7

EV/EBITDA

15.5

Company Profile

Country (HQ)

Japan

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Takashi Shibata open_in_new

Employees

220

Founded

1946

Website

seirogan.co.jp open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.3%	-1%	-3.3%	3.9%	4.7%	-2%	5.8%	-24%	-76%

News

Markets

Exchange	Ticker	Price	Quotes
Tokyo Stock Exchange (TSE / TYO) MIC: XTKS PRIMARY	4574 大幸薬品株式会社 ISIN: JP3442200006 Shares Out.: Shares Outstanding: 50.251M¹ Shares Float: 33.961M² TV: TradingView: TSE: 4574 SA: Stock Analysis: TYO: 4574 YF: Yahoo Finance: 4574.T GF: Google Finance: TYO: 4574 BA: Barron's: 4574 MS: Morningstar: XTKS: 4574	292 JPY	TV: TradingView: TSE: 4574 SA: Stock Analysis: TYO: 4574 YF: Yahoo Finance: 4574.T GF: Google Finance: TYO: 4574 BA: Barron's: 4574 MS: Morningstar: XTKS: 4574

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Taiko Pharmaceutical Co.,Ltd.

Taiko Pharmaceutical Co.,Ltd. manufactures and sells over-the-counter (OTC) medicines and quasi drugs in Japan and internationally. The company provides OTC medicines under the SEIROGAN, SEIROGAN TOI A and SEIROGAN Quick C, PISHUT OD Tablet brand names; and quasi-drugs under the RAPPA INTESTINAL REGULATOR BF brand names. It offers sanitation control products under the Cleverin PR, Cleverin Pro Stick, and Cleverin Pro name. In addition, the company manufactures and sells wood vinegar-based products. It exports its products. The company was incorporated in 1946 and is headquartered in Osaka, Japan.

Similar Companies

Industry: Drug Manufacturers - General (Japan)

Name	Market Cap (USD) diff.	PE	Country
Chugai Pharmaceutical Co., Ltd. TSE: 4519	$81.51B 13.07T JPY 89K%	28.9	Japan
Takeda Pharmaceutical Company Ltd. TSE: 4502	$52.12B 8.36T JPY 57K%	75.1	Japan
Otsuka Holdings Co., Ltd. TSE: 4578	$36.77B 5.9T JPY 40K%	15.7	Japan
Daiichi Sankyo Company, Ltd. TSE: 4568	$30.32B 4.86T JPY 33K%	16.2	Japan
Astellas Pharma Inc. TSE: 4503	$25.77B 4.13T JPY 28K%	14.2	Japan
Shionogi & Co., Ltd. TSE: 4507	$16.88B 2.71T JPY 18K%	13.9	Japan

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 832K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 598K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 394K%	97.4	United States
Roche Holding AG SIX: RO	$324.68B 256.25B CHF 355K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.43B 215.59B GBP 316K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$277.35B 218.9B CHF 303K%	20.5	Switzerland

chevron_leftBack